The battle against flu: how can technology help?

15 February 2017

According to Public Health England’s Annual Flu Report, there have been more than three million deaths in the UK since 2006 from flu. In an expert view piece, Nick Hawkins, managing director for EMEA at global mass notifications software provider Everbridge, shows how mass notification solutions can be used to stop the death toll rising.

Recent figures released by the Office for National Statistics (ONS) show that last year an ineffective vaccine combined with low immunization rates across the UK resulted in the largest increase in flu deaths since 1968.

Who is most at risk?

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK